Ralf Paschke
About
Ralf Paschke is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology.
According to data from OpenAlex, Ralf Paschke has authored 268 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Endocrinology, Diabetes and Metabolism, 67 papers in Molecular Biology and 50 papers in Epidemiology. Recurrent topics in Ralf Paschke's work include Thyroid Cancer Diagnosis and Treatment (133 papers), Thyroid Disorders and Treatments (84 papers) and Adipokines, Inflammation, and Metabolic Diseases (26 papers). Ralf Paschke is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (133 papers), Thyroid Disorders and Treatments (84 papers) and Adipokines, Inflammation, and Metabolic Diseases (26 papers). Ralf Paschke collaborates with scholars based in Germany, United States and Canada. Ralf Paschke's co-authors include Mathias Faßhauer, Markus Eszlinger, Johannes Klein, László Hegedüs, Matthias Blüher, Enrico Papini, Susanne Neumann, Knut Krohn, Roberto Valcavi and Ulrike Lössner and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
In The Last Decade
Ralf Paschke
260 papers receiving 13.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ralf Paschke Germany | 59 | 8.8k | 4.0k | 3.4k | 2.9k | 2.2k | 268 | 14.3k | ||
| Johannes W. A. Smit Netherlands | 75 | 12.5k 1.4× | 5.1k 1.3× | 3.2k 0.9× | 3.9k 1.3× | 1.9k 0.9× | 493 | 22.1k | ||
| Paolo Vitti Italy | 61 | 11.9k 1.3× | 4.3k 1.1× | 1.5k 0.4× | 2.4k 0.8× | 913 0.4× | 337 | 15.6k | ||
| Faramarz Ismail‐Beigi United States | 53 | 9.3k 1.1× | 2.8k 0.7× | 1.6k 0.5× | 5.0k 1.7× | 2.4k 1.1× | 203 | 16.6k | ||
| Kenneth D. Burman United States | 55 | 9.3k 1.1× | 2.0k 0.5× | 955 0.3× | 2.4k 0.8× | 1.1k 0.5× | 310 | 13.3k | ||
| Aldo Pinchera Italy | 91 | 20.2k 2.3× | 6.1k 1.5× | 3.1k 0.9× | 4.8k 1.6× | 1.7k 0.8× | 578 | 28.7k | ||
| Shun Ishibashi Japan | 67 | 4.1k 0.5× | 6.4k 1.6× | 3.2k 0.9× | 6.6k 2.3× | 3.0k 1.4× | 360 | 17.2k | ||
| Riccardo Vigneri Italy | 69 | 10.2k 1.2× | 4.4k 1.1× | 1.7k 0.5× | 8.6k 2.9× | 1.6k 0.7× | 303 | 18.3k | ||
| Paul W. Ladenson United States | 63 | 10.5k 1.2× | 3.4k 0.8× | 1.4k 0.4× | 2.3k 0.8× | 501 0.2× | 176 | 13.7k | ||
| Luca Chiovato Italy | 59 | 7.7k 0.9× | 1.6k 0.4× | 1.3k 0.4× | 2.4k 0.8× | 848 0.4× | 333 | 13.8k | ||
| François Cambien France | 71 | 7.0k 0.8× | 3.2k 0.8× | 2.1k 0.6× | 3.9k 1.4× | 1.8k 0.8× | 229 | 20.8k |
Countries citing papers authored by Ralf Paschke
Since
Specialization
Citations
This map shows the geographic impact of Ralf Paschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Paschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Paschke more than expected).
Fields of papers citing papers by Ralf Paschke
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ralf Paschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Paschke. The network helps show where Ralf Paschke may publish in the future.
Co-authorship network of co-authors of Ralf Paschke
This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Paschke. A scholar is included among the top collaborators of Ralf Paschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Paschke. Ralf Paschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Paschke, Ralf, Syed Ali Imran, Heather Lochnan, et al.. (2025). Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada. European Thyroid Journal. 14(3).
2.
Wu, J., et al.. (2025). Development of a Nomogram to Integrate Molecular Testing and Clinical Variables to Improve Malignancy Risk Assessment Among Cytologically Indeterminate Thyroid Nodules. Thyroid. 35(5). 508–515.
3.
McIntyre, John B., et al.. (2024). Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers. European Thyroid Journal. 13(3).
4.
Wu, J., et al.. (2023). Improvement in neck ultrasound report quality following the implementation of European Thyroid Association guidelines for postoperative cervical ultrasound for thyroid cancer follow-up, a prospective population study. European Thyroid Journal. 12(5).
5.
Eszlinger, Markus, et al.. (2023). Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice. European Thyroid Journal. 12(6).
6.
Durante, Cosimo, László Hegedüs, Agnieszka Czarniecka, et al.. (2023). 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. European Thyroid Journal. 12(5).
7.
Eszlinger, Markus, J. Wu, Moosa Khalil, et al.. (2023). Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization. Thyroid. 33(12). 1423–1433.
8.
Eszlinger, Markus, et al.. (2022). DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer. European Journal of Endocrinology. 187(3). R41–R52.
9.
Wu, J., et al.. (2022). Improvement in thyroid ultrasound report quality with radiologists’ adherence to 2015 ATA or 2017 TIRADS: a population study. European Thyroid Journal. 11(3).
10.
Ho, Alan L., Marek Dedecjus, Lori J. Wirth, et al.. (2022). Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). Journal of Clinical Oncology. 40(17). 1870–1878.
11.
Moretti, Rocco, et al.. (2022). Integrative model of the FSH receptor reveals the structural role of the flexible hinge region. Structure. 30(10). 1424–1431.e3.
12.
Wu, J., Christopher Symonds, Peter Grundy, et al.. (2022). The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting. Thyroid. 32(12). 1509–1518.
13.
Lau, Lorraine, et al.. (2021). Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis. Thyroid Research. 14(1). 3–3.
14.
Lincke, Thomas, et al.. (2019). Myocardial Infarction after Long-Term Treatment with a Tyrosine Kinase Inhibitor (TKI) with Anti-VEGF Receptor Activity. Case Reports in Endocrinology. 2019. 1–3.
15.
Schaarschmidt, Jörg, Holger Jaeschke, Rocco Moretti, et al.. (2016). Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation. Journal of Biological Chemistry. 291(27). 14095–14108.
16.
Kwon, Hyemi, Won Gu Kim, Markus Eszlinger, et al.. (2016). Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules. Endocrinology and Metabolism. 31(4). 586–586.
17.
Grußendorf, M, Christoph Reiners, Ralf Paschke, & Karl Wegscheider. (2011). Reduction of Thyroid Nodule Volume by Levothyroxine and Iodine Alone and in Combination: A Randomized, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 96(9). 2786–2795.
18.
Gharib, Hossein, Ralf Paschke, Daniel S. Duick, et al.. (2010). American Association of ClinicalEndocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules: Executive Summary of Recommendations. Endocrine Practice. 16(3). 468–475.
19.
Vierimaa, Outi, Marianthi Georgitsi, Rainer Lehtonen, et al.. (2006). Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene. Science. 312(5777). 1228–1230.
20.
Eszlinger, Markus, Knut Krohn, & Ralf Paschke. (2001). Complementary DNA Expression Array Analysis Suggests a Lower Expression of Signal Transduction Proteins and Receptors in Cold and Hot Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 86(10). 4834–4842.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Johannes W. A. Smit Breakdown of academic impact, for papers by Paolo Vitti Breakdown of academic impact, for papers by Faramarz Ismail‐Beigi Breakdown of academic impact, for papers by Kenneth D. Burman Breakdown of academic impact, for papers by Aldo Pinchera Breakdown of academic impact, for papers by Shun Ishibashi Breakdown of academic impact, for papers by Riccardo Vigneri Breakdown of academic impact, for papers by Paul W. Ladenson Breakdown of academic impact, for papers by Luca Chiovato Breakdown of academic impact, for papers by François Cambien